Overview of the Region X HIV Programme, including data on population, PLHIV, and the HIV care cascade. Mobilizing, testing, linkage, ART initiation, treatment and retention, challenges among specific populations, and other challenges are discussed.

6 views • 9 slides

Guideline aims to recognize the risks, signs, and symptoms of acute HIV infection and to promote HIV testing in individuals presenting with flu-like symptoms or viral syndromes. It provides recommendations for diagnostic testing, treatment, and prevention services to improve patient health and reduc

0 views • 19 slides

A systematic review was conducted to assess the proportion of adult HIV patients in sub-Saharan Africa with prior antiretroviral therapy experience, specifically focusing on non-naive re-initiators. The study highlighted the challenges faced by these individuals and the need for tailored interventio

0 views • 11 slides

Globally, cervical cancer is the fourth most common cancer in women, with 6,04,000 new cases in 2020. Women living with HIV are 6 times more likely to develop cervical cancer, compared to the general population, and an estimated 5% of all cervical cancer cases are attributable to HIV. The contributi

2 views • 7 slides

The Global Fund has been supporting HIV, TB, and Malaria programs in India since 2002, with significant grant disbursements. Consultations and meetings have paved the way for allocating funds and determining priorities for the upcoming grant period. The allocation split between NACO and NGPR has bee

0 views • 13 slides

This update highlights key points from the PMK No. 23/2022 on combating HIV, AIDS, and STIs. It covers terminologies, goals for eliminating HIV and AIDS by 2030, and strategies such as PrEP and PEP. The guidelines emphasize timely interventions like Post-Exposure Prophylaxis (PEP) and Pre-Exposure P

3 views • 38 slides

In sub-Saharan Africa, a study was conducted among Lake Victoria fishermen in Kenya to assess the effectiveness of a social network-based intervention in improving HIV testing and linkage outcomes. Results showed significantly higher rates of HIV self-testing and linkage to health facilities in the

0 views • 19 slides

Cardiovascular disease is a growing concern in individuals living with HIV, despite advancements in treatment. The REPRIEVE Trial sheds light on the importance of assessing cardiovascular risk and implementing primary prevention measures in this population. Dr. Grinspoon's financial disclosures and

0 views • 35 slides

Explore essential information on HIV and AIDS, including transmission myths, definitions, the importance of people-first language, and statistics specific to Oklahoma. Learn about the impact of HIV/AIDS in the United States and why accurate understanding and language are crucial in addressing this p

3 views • 35 slides

Anaemia can result from various causes such as blood loss, increased destruction of red blood cells, and impaired production, often linked to infections and chronic diseases. Parasites, bacteria, and viruses play a role in the progression of anaemia, affecting the body's ability to produce and utili

3 views • 10 slides

Nontuberculous mycobacteria (NTM) infections present a significant challenge in individuals with cystic fibrosis (CF). These infections are caused by over 200 species of atypical mycobacteria found in various environments. The CF-ID Clinic plays a crucial role in managing patients with multi-drug re

2 views • 25 slides

HIV and AIDS are closely related, with HIV being the virus that leads to AIDS. HIV weakens the immune system by attacking specific white blood cells, while AIDS is the advanced stage of HIV infection. Prevention is crucial as AIDS is a deadly, incurable disease. The transmission of HIV primarily occ

4 views • 14 slides

The REPRIEVE trial focuses on developing a cardiovascular disease prevention strategy for individuals living with HIV. It addresses the increased risk of CVD in this population, even with good viral suppression. The study evaluates the use of pitavastatin, a statin with anti-inflammatory properties,

1 views • 33 slides

This study estimates the burden of serious fungal infections in Indonesia, a country with rich biodiversity and limited medical mycology facilities. The data indicates a high prevalence of opportunistic infections in AIDS patients and TB cases, with Candidiasis and Cryptococcosis being significant c

2 views • 29 slides

Explore how differentiated care is revolutionizing HIV service delivery by shifting the focus to client-centered approaches. Learn about the current challenges in facility-based care, the needs of people living with HIV, best practices from various countries, and innovative ways to provide different

0 views • 8 slides

HIV, a member of the lentivirus subfamily of retroviruses, causes Acquired Immunodeficiency Syndrome (AIDS). HIV-1 and HIV-2 have distinct characteristics, with HIV-1 being global and HIV-2 primarily in West Africa. The virus encodes reverse transcriptase and has an envelope containing glycoproteins

1 views • 31 slides

Anaerobic bacterial infections are caused by bacteria that do not require oxygen for growth, posing challenges in diagnosis and treatment. This article delves into the types of anaerobic bacteria, their role in human infections, and common clinical presentations such as abscess formation. Gram-negat

1 views • 24 slides

GLP-1 receptor agonists offer a promising therapeutic approach for weight management in individuals with HIV. Weight gain is a common issue, exacerbated by antiretroviral therapy, and can lead to metabolic risks. This presentation by Dr. Suman Srinivasa discusses the potential of GLP-1 receptor agon

2 views • 32 slides

Communicable Disease Harm Reduction Section collaborated with Simple HealthKit to offer free HIV, syphilis, gonorrhea, chlamydia, and trichomoniasis testing to Wisconsin residents over 18 from August 25, 2023, to October 20, 2023. The aim was to make HIV and STI testing more accessible to those with

0 views • 23 slides

The global AIDS epidemic in 2020 saw 37.7 million adults and children living with HIV, with 1.5 million new infections and 680,000 AIDS-related deaths. Africa remains heavily affected, with 60% of new infections occurring in sub-Saharan Africa. The data highlights the continued challenges in combati

2 views • 11 slides

Explore the world of fungi and fungal infections in this foundation block of microbiology. Learn about medically important yeasts, mold fungi, major fungal diseases, antifungal agents, and infection acquisition methods. Dive into hypersensitivity reactions, mycotoxicoses, and various types of fungal

1 views • 19 slides

Malnutrition is common in people living with HIV and TB, exacerbating immune suppression and disease progression. Good nutrition can strengthen the immune system, improve drug adherence, and manage symptoms, while poor nutrition weakens immunity and increases vulnerability to infections. Consequence

2 views • 20 slides

Combination antiretroviral therapy (ART) is effective against HIV but can lead to drug resistance if not taken consistently. HIV mutates rapidly, increasing the risk of drug-resistant strains emerging. Learn about the causes, types of resistance, testing methods, and prevention strategies to combat

0 views • 23 slides

Viral infections exhibit diverse cellular tropism based on receptor interactions, impacting cell function through modulation and potential host defense responses. Infections can lead to various outcomes, from cell death to persistent or latent states, with nuanced effects on cellular behavior. Diffe

0 views • 8 slides

Protozoal infections, such as amebiasis, are a significant concern globally. In underdeveloped regions and beyond, these infections pose challenges due to inadequate sanitation and hygiene practices. Antiamebic drugs are essential for treating conditions like amebiasis, caused by Entamoeba histolyti

0 views • 40 slides

HIV Post-Exposure Prophylaxis (PEP) is a crucial emergency medical response for individuals exposed to HIV, aiming to prevent infection. It involves a regimen of medications, tests, and counseling services initiated within 72 hours of exposure. HIV transmission occurs through body fluids like blood,

3 views • 27 slides

Human Immunodeficiency Virus (HIV) is a retrovirus causing Acquired Immunodeficiency Syndrome (AIDS). HIV leads to immune system destruction, making individuals vulnerable to opportunistic infections and tumors. Common sexually transmitted diseases like syphilis, chlamydia, and gonorrhea are discuss

3 views • 15 slides

This content provides an overview of the relationship between TB and HIV, emphasizing the importance of testing HIV patients for latent TB infection and TB patients for HIV. It also outlines the guidelines for managing these co-infections, including diagnostic tests, treatment strategies, and patien

0 views • 17 slides

West Sussex's HIV testing plan for 2022-2025 focuses on reducing domestic transmissions by implementing targeted strategies in primary and secondary care settings. While overall prevalence is low, certain areas in West Sussex exhibit higher rates, necessitating tailored testing approaches. The plan

0 views • 6 slides

Persistent gaps in condom use hinder countries from achieving HIV prevention goals. The initiative aims to improve aligned support for HIV prevention beyond traditional condom strategies. Condoms play a crucial role in reducing new infections, alongside treatment, biomedical interventions, behavior

0 views • 13 slides

Exploring the various co-morbidities associated with HIV infection and factors contributing to their development. Discussions on disease clusters, impact of risk factors such as smoking and cardiovascular disease, and comorbidities in parents of PLWH compared to HIV-negative individuals. Insights in

0 views • 14 slides

PEPFAR is intensifying efforts on partner notification services for HIV prevention to address the global issue of undiagnosed HIV cases. The initiative aims to improve testing strategies, increase testing volumes, and enhance epidemic control. By reaching HIV testing targets and implementing efficie

0 views • 24 slides

Anthelmintics are essential drugs to combat parasitic worm infections in animals. They work either by killing (vermicide) or expelling (vermifuge) the worms, reducing worm burdens and controlling infections. This comprehensive overview covers different aspects of anthelmintics, including their prope

2 views • 34 slides

Understanding the importance of early diagnosis in HIV-infected infants and children is crucial for timely intervention and improved health outcomes. This session covers testing algorithms, initiation of antiretroviral therapy, viral load monitoring, and legal issues related to HIV testing in childr

2 views • 31 slides

This lecture covers the classification of respiratory tract infections and the antibiotics commonly used to treat them. It highlights the types of infections caused by viruses and bacteria, along with their respective treatments. The mechanism of action and pharmacokinetics of antibiotics, such as p

0 views • 7 slides

This study led by Dr. Geoffrey Chipungu, an HIV/AIDS Specialist at UNICEF ESARO, explores the rates, trends, and factors associated with HIV viral load suppression (VLS) in children. The research reveals sub-optimal VLS rates in children compared to adults, highlighting the need for improved policie

2 views • 12 slides

Infectious Diseases class focuses on various topics including Antibiotic Stewardship Practices, Community-Acquired Infections, Gram-Positive and Gram-Negative Bacteria, Spirochetal Diseases, Diseases Caused by Bacterial and Viral Infections, HIV/AIDS, Fungal and Parasitic Infections. The class also

1 views • 30 slides

Update on advanced HIV disease in South Africa highlights progress in reducing AIDS-related deaths, prevalence rates, and advancements in coordinating and implementing policies and guidelines for HIV/AIDS response. The report covers statistics on HIV prevalence, ART facilities, mortality rates, and

0 views • 17 slides

HIV, Human Immunodeficiency Virus, attacks the immune system and can progress to AIDS if left untreated. Antiretroviral Therapy (ART) helps control HIV, allowing individuals to live healthy lives. The stages of HIV include Acute Infection, Chronic Infection, and the most severe stage, AIDS. Early de

0 views • 29 slides

Under this program, District Master Training on the Introduction of DTG for HIV Infection Treatment is provided, supported by the Knowledge Hub. The initiative offers training materials, guidelines, and videos, accessible through the Knowledge Hub platform. Participants can register through SkillSMA

0 views • 8 slides